Determination of atractylenolide II in rat plasma by reversed-phase high-performance liquid chromatography

Biomedical Chromatography

Volumn 21, Issue 3, 2007, Pages 299-303

  Ge, Jian ^a,d   Wang, You Wei ^b,e   Lu, Xiao Cong ^c   Sun, Xiao Hong ^a   Gong, Fu Jun ^a  

^a Wuhan Institute of Botany Chinese Academy of Sciences   (China)

^b WUHAN UNIVERSITY   (China)

^c Hubei Center for Disease Control and Prevention   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^e NONE   (China)

Author keywords

Atractylenolide II; Pharmacokinetics; RP HPLC

Indexed keywords

BODY FLUIDS; RATS;

ATRACTYLENOLIDE II; ETHYL-ACETATE; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; INTERNAL STANDARDS; PLASMA SAMPLES; QUANTITATIVE DETERMINATIONS; RAT PLASMA; REVERSED-PHASE HIGH PERFORMANCE; REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; UV SPECTROMETRY;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ATRACTYLENOLIDE; ATRACTYLODES EXTRACT; UNCLASSIFIED DRUG;

ACCURACY; ANALYSIS OF COVARIANCE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG ISOLATION; DRUG STABILITY; LIQUID LIQUID EXTRACTION; MALE; NONHUMAN; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; SPECTROPHOTOMETER; VALIDATION PROCESS; WISTAR RAT;

RATTUS;

EID: 33947609214     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.756     Document Type: Article

References (21)

1. Cai H, Steward WP and Gescher AJ. Determination of the putative cancer chemopreventive flavone tricin in plasma and tissues of mice by HPLC with UV-visible detection. Biomedical Chromatography, 2005; 7: 518-522.
2. Chen A, Li C, Gao W, Hu Z and Chen X. Separation and determination of active components in Schisandra chinensis Baill. and its medicinal preparations by non-aqueous capillary electrophoresis. Biomedical Chromatography, 2005; 7: 481-487.
3. Cui S, Qi S, Chen X and Hu Z. Identification and determination of effective components in Euphrasia regelii by capillary zone electrophoresis. Biomedical Chromatography 2004; 10: 857-861.
4. Dong Z, Li S, Hong M and Zhu Q. Hypothesis of potential active components in Angelica sinensis by using biomembrance extraction and high performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 2005; 38: 664-669.
5. Endo K, Taguchi T, Taguchi F, Hikina H, Yahahara J and Fujimura H. Antiinflammatory Principles of atractylodes rhizomes. Chemical and Pharmaceutical Bulletin 1979; 27: 2954-2958.
6. Gu W, Zhu D and Yan Y. Studies on chemical constituents of danggui shaoyao and its mechanism in preventing and treatment of senile dementia vi-active chemical components. Chinese Journal of Experimental Traditional Medical Formulae 2004; 10:1-3.
7. Hikino H, Hikino Y and Yosioka I. Studies on the constituents of atractylodes. IX. Structure and autoxidation of atractylon. Chemical and Pharmaceutical Bulletin 1964; 7: 755-760.
8. Huang L, Liang Y, Guo F, Zhou Z and Chen B. Simultaneous sepatation and determination of active components in Cordyceps sinensis and Cordyceps militarris by LC/ESI-MS. Journal of Pharmaceutical and Biomedical Analysis 2003; 33:1155-1162.
9. Li FLY. Determination of trimebutine maleate in rat plasma and tissues by using capillary zone electrophoresis. Biomedical Chromatography 2001; 4: 248-251.
10. Li W, Wen H, Zhang A, Ge J and Wu H. Study on quality of atractylodes macrocephala Koidz - determination of 2 atractylenolides by HPLC. Chinese Journal of Pharmaceutical Analysis 2001; 21: 170-172.
11. Li X, Xiao H, Liang X, Shi D and Liu J. LC-MS/MS determination of naringin, hesperidin and neohesperidin in rat serum after orally adminstrating the decoction of Bulpleurum falcatum L. and Fractus aurantii. Journal of Pharmaceutical and Biomedical Analysis 2004; 34: 159-166.
12. Li Y, Xiong Z and Li F. Deternination of epimedin C in rat plasma by reversed-phase high-performance chromatography after oral administration of Herba Epimedii extract. Journal of Chromatography B 2005; 821: 235-239.
13. Lin R, Tian J, Huang G, Li T and Li F. Analysis of menthol in three traditional Chinese medicinal herbs and their compound formulation by GC-MS. Biomedical Chromatography 2002; 3: 229-233.
14. Liu Y, Qiu G, Zhang M, Wang R, He Q and Cai Y. Effects of lactone II from Atractylodes macrocephala Koidz on cytokines and proteolysis inducing factors in cachectic cancer patients. Journal of First Military Medical University 2005; 10: 1308-1311.
15. Matsuda H, Li Y, Taniguchi K, Yamahara J and Tamai Y. Imaging analysis of antiulcer action and the active constituent of atractylodis rhizoma. Yakugaku Zasshi 1991; 111: 36-39.
16. Pachaly P, Lansing A and Sin KS. Constituents of Atractylis koreana. Planta Medica 1989; 55: 59-61.
17. Sheng Y, Li L, Zhang J and Guo D. Simultaneous determination of albiflorin and paeoniflorin in rat urine by solid-phase extraction and high-performance liquid chromatography following oral administration of Si-Wu decoction. Biomedical Chromatography 2004; 10: 759-784.
18. Sun J, Wang G, Xie H, Li H, Pan G and Ian T., Simultaneous rapid quantification of ginsenoside Rg1 and its secondary glycoside Rh1 and aglycone protopanaxatriol in rat plasma by liquid chromatography - mass spectrometry after solid-phase extraction. Journal of Pharmaceutical and Biomedical Analysis 2005; 38: 126-132.
19. The Pharmacopoeia Committee of China. The Chinese Pharmacopoeia, Part I. The Chemical Industry Publishing House: Beijing, 2000.
20. Yu Y, Song C and Jia T. Quality standard of processed products of Rhizoma Atractylodis macrocephalae. Chinese Traditional Patent Medicine 2005; 6: 669-672.
21. Zhang Y, Xu S and Lin Y. Gastrointestinal inhibitory effects of Sesquiterpene Lactones from Atractylodes macrocephala. Journal of Chinese Medicinal Materials 1999; 12: 636-640.